Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Naquotinib mesylate (ASP8273 (mesylate)) is an orally available, mutant-selective and irreversible inhibitor of EGFR(iC50s of 8-33 nM and 230 nM for toward EGFR mutants and EGFR).
説明 | Naquotinib mesylate (ASP8273 (mesylate)) is an orally available, mutant-selective and irreversible inhibitor of EGFR(iC50s of 8-33 nM and 230 nM for toward EGFR mutants and EGFR). |
ターゲット&IC50 | EGFR:230 nM |
別名 | ASP8273 (mesylate) |
分子量 | 658.81 |
分子式 | C31H46N8O6S |
CAS No. | 1448237-05-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12.5 mg/mL (18.97 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Naquotinib mesylate 1448237-05-5 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR ErbB-1 ASP8273 (mesylate) Inhibitor ASP8273 ASP 8273 HER1 Epidermal growth factor receptor inhibit Naquotinib Mesylate ASP-8273 Naquotinib inhibitor